Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Revlimid 7.5 mg Hard Capsules {equilateral_black_triangle}

Active Ingredient:
lenalidomide
Company:  
Bristol Myers Squibb Pharmaceuticals limited See contact details
ATC code: 
L04AX04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Live Chat HCP Med Info
{arrow_left}
{arrow_right}

This chat facility is provided by the company that holds the marketing authorisation for the medicine


Click here to connect to Chat

Click to Chat is a service provided for healthcare professionals. You can use the chat facility to contact BMS about prescription only medicines. Chat is not intended for use to report Adverse Events or Product Quality Complaints. To report an Adverse Event or Product Quality Complaint, please call us on 0800 7311 736.

Click to chat is open during the hours of 9.00am – 5.00pm Mon-Fri excluding bank holidays.

NOUK1801276-01-01 11/18
Bristol Myers Squibb Pharmaceuticals limited
Company image
Address
Bristol-Myers Squibb, ARC Uxbridge, Sanderson Road, New Denham, Denham, Buckinghamshire, UB8 1DH, UK
Telephone
+44 (0)1895 523 000
Medical Information e-mail
[email protected]
Medical Information Direct Line
+44 (0) 800 731 1736
Medical Information Website
https://www.bmsmedinfo.co.uk/